- School of Health Preservation and Rehabilitation, Chengdu University of Traditional Chinese Medicine, Chengdu, China
Introduction: The high-salt diet is a prevalent eating habit associated with health risks. This study investigated the impact of high salt on intestinal barrier disruption and gut microbiome dysbiosis using Wistar and Dahl salt-sensitive rat models.
Methods: Rats were fed a normal diet or a high-salt diet for eight weeks. Body weight and plasma inflammatory cytokines were monitored in the study. Colon tissue damage was assessed via histopathological examination, and metagenomic sequencing was utilized to analyze alterations in microbial composition, functional pathways, and biodiversity.
Results: The results indicated that high salt significantly elevated pro-inflammatory cytokine levels and induced structural damage in the colon. Metagenomic analysis revealed that high salt concentrations resulted in approximately a 15% difference in microbial species composition. And led to a decrease in Alpha diversity, along with an increase in the Firmicutes/Bacteroidetes ratio. Taxon-specific alterations included reduced abundance of Lactobacillus and Clostridium, and increased abundance of Enterobacter and Bifidobacterium. Correlation analyses further revealed a positive correlation between Bifidobacterium abundance and tumor necrosis factor-α level in Dahl salt-sensitive rats.
Discussion: This study illuminates the gut microbiota’s role in salt-sensitivity and provides a foundational basis for developing microbiota-targeted interventions for at-risk individuals.
1 Introduction
The high-salt diet (HSD) is a common yet frequently overlooked unhealthy eating habit that leads to various chronic diseases (Kwong et al., 2023; Wang et al., 2025), such as hypertension, obesity, and multi-organ impairment (Abdelnour et al., 2020; Allen et al., 2019; Li et al., 2019). Given that the impacts of high salt intake may vary among individuals with different constitutions and likely involve multiple mechanisms, it is imperative to identify a universal physiological process that can explain the underlying mechanisms of HSD effects.
The gut harbors a vast array of microorganisms, predominantly bacteria, collectively referred to as the gut microbiota (Huang et al., 2024). These bacteria and their metabolites participate in regulating multiple physiological processes in the host (Li et al., 2023). Owing to the enormous number of genes encoded by the gut microbiota, it is often regarded as the second genome (Zhang et al., 2022; Feng et al., 2024). Recent studies indicate that gut microbial dysbiosis is a key mechanism in the pathogenesis of various disorders (Li et al., 2024a,b; Mu et al., 2024a,b; Wang et al., 2024; Mu et al., 2024a,b; Padhi et al., 2022). For instance, HSD modulates the abundance of Lactobacillus and Bacteroides, leading to elevated levels of pro-inflammatory T helper 17 (Th17) cells and enteric corticosterone, thereby contributing to hypertension and vascular pathology (Wilck et al., 2017a,b; Yan et al., 2020a,b; Monteleone et al., 2017). Additionally, high salt intake alters the abundance of Proteobacteria and Bacteroidetes, while increasing the levels of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6), ultimately inducing inflammation (Guo et al., 2021; Li et al., 2020; Ma et al., 2020). The gut microbiota, along with its critical metabolites and signaling molecules, has recently garnered considerable attention across various branches of medicine (Li et al., 2024a,b; Miranda et al., 2018; Shen et al., 2021). It is considered a highly promising target for research, offering novel insights into the mechanisms underlying the effects of HSD (Xu et al., 2024). Therefore, utilizing animal models with well-defined genetic backgrounds to dissect the role of salt sensitivity in the HSD–gut microbiota–host health axis has important translational significance for identifying at-risk human populations and developing targeted microbiome-based intervention strategies.
In summary, this study builds upon previous research to confirm that HSD induces inflammatory injury and disrupts gut microbial ecology. In contrast to previous studies focusing on a single model, our study employs a parallel comparative design using both Wistar and Dahl salt-sensitive rats to decipher how host salt sensitivity dictates the gut microbiota’s response to HSD. Additionally, Further research investigates the mechanisms through which high salt intake affects the host via the gut microbiota. Wistar and Dahl salt-sensitive rats were selected as animal models for comparative analysis of salt-sensitivity-related damage. The Dahl salt-sensitive rat is widely recognized as one of the gold-standard models for studying salt-sensitive hypertension and end-organ damage in humans, given its strong pathophysiological resemblance to the human condition. Adverse physiological effects were assessed through changes in body weight and plasma inflammatory cytokine levels, while colon histopathology was used to evaluate structural damage to the intestinal tissue. Metagenomic sequencing of fecal samples was employed to detect enriched functional pathways and assess microbial richness and diversity. Correlation analysis was applied to explore the relationship between inflammatory damage and alterations in the gut microbiota. This study aims to provide a theoretical basis for the clinical prevention and mitigation of HSD-related health risks. The main schematic flowchart of this study is shown in Figure 1.
Figure 1. A schematic flowchart illustrating the overall experimental design and research procedures of this study.
2 Materials and methods
2.1 Animals and diet
Wistar rats and Dahl salt-sensitive rats were obtained from SiPeiFu Biotechnology Co., Ltd. (Beijing, China). The rat feeds were purchased from KeaoXieli Feed Co., Ltd. (Beijing, China). To eliminate potential confounding effects of estrogen on body weight and other parameters, only male rats were used in this study. Animals (n = 12 DahL salt-sensitive rats, n = 12 Wistar) were housed under controlled conditions (22 ± 1 °C, 50–60% humidity, 12 h light/dark cycle) with ad libitum access to food and purified water. Following a one-week acclimatization period, Dahl salt-sensitive rats were randomly assigned to the normal control group (DC group, 0.3% NaCl diet feeding) or HSD group (DH group, 8% NaCl diet feeding). Similarly, Wistar rats were randomly assigned to the normal control group (WC group, 0.3% NaCl diet feeding) or HSD group (WH group, 8% NaCl diet feeding). The catalog numbers for the 0.3% NaCl diet and the 8% NaCl diet are 1,016,712,327,837,081,600 and 1,016,706,714,625,204,224, respectively. Diet compositions are detailed in Supplementary Table S1. Our animal study is reported in accordance with the ARRIVE (animal research: reporting of in vivo experiments) guidelines. All experimental procedures were approved by the Experimental Animal Ethics Committee of Chengdu University of Traditional Chinese Medicine (Ethics Approval No.: 2018-21).
2.2 Sample collection
At the end of acclimatization and weeks 2, 4, 6, and 8 post-modeling, body weights of all rats were measured using an electronic laboratory balance. Afterward, Rats were then anesthetized with 1% pentobarbital sodium (30 mg/kg) and euthanized. Blood samples (~10 mL/rat) were collected from the abdominal aorta, centrifuged at 3,000 × g for 10 min at 4 °C to obtain plasma, and stored at −80 °C. Plasma TNF-α, IL-6, interleukin-1β (IL-1β), and interleukin-10 (IL-10) levels were quantified using enzyme linked immunosorbent assay (ELISA) kits (Elabscience Biotechnology, Wuhan, China). Both the intra-assay and inter-assay coefficients of variation for all cytokine measurements were confirmed to be less than 10%. The specific sensitivity and detection range for each assay kit are provided in Supplementary Table S2. Following colon dissection with sterilized scissors, 2–3 fecal pellets were collected from the lumen using sterile forceps and aliquoted into 2-mL cryovials. Adjacent colon segments were harvested for histopathological analysis. All samples were stored at −80 °C until use.
2.3 Colon histopathological examination
The Colon samples were fixed in 10% neutral buffered formalin, processed routinely, embedded in paraffin, and sectioned at a thickness of 4 μm. Consecutive sections were subjected to either hematoxylin and eosin (H&E) staining for general histopathological evaluation or periodic acid-Schiff (PAS) staining for neutral mucins and basement membrane visualization. All stained sections were examined under an optical microscope. Representative images of colonic mucosa were captured at 200x magnification to assess overall tissue architecture (H&E) and mucin distribution/goblet cell abundance (PAS), and at 400× magnification to evaluate cellular details (H&E) as well as basement membrane integrity and detailed goblet cell morphology/mucin content (PAS).
2.4 Fecal metagenomic profiling
2.4.1 DNA extraction
Genomic DNA was extracted from 0.25 g of thawed fecal sample using a commercial kit (QIAamp PowerFecal Pro DNA Kit, Qiagen, Germany). Samples were homogenized with solution C1, followed by a series of steps involving incubation with solutions C2 and C3, binding of DNA with solution C4, washing with solution C5, and final elution with solution C6. All centrifugation steps were performed at 10,000 × g at room temperature. The extracted DNA was stored at −20 °C for subsequent analysis.
2.4.2 DNA shearing
A quantified amount of genomic DNA (as determined by Qubit fluorometer) was diluted to 100 μL with 1 × TE buffer (on ice). The DNA was mechanically sheared using a focused-ultrasonicator (Covaris, USA) according to the manufacturer’s recommendations to generate fragments of the desired size distribution. The fragmentation efficiency was verified by agarose gel electrophoresis.
2.4.3 Purification of sheared products
The fragmented DNA was purified using AMPure XP beads (Beckman Coulter, USA) at a ratio of 1:1 (v/v). The mixture was incubated at room temperature for 5 min, separated on a magnetic stand, and the supernatant was discarded. The beads were washed twice with 80% ethanol, air-dried, and the DNA was eluted in 0.1 × TE buffer.
2.4.4 End repair and adapter ligation
The purified DNA was subjected to end repair using a combination of buffer and end repair enzyme mix. The reaction was incubated in a thermal cycler. Subsequently, Illumina-compatible adapters and DNA ligase were added to the reaction mixture for adapter ligation under controlled conditions.
2.4.5 Size selection and purification
Adapter-ligated DNA was purified and size-selected using a double-sided SPRI bead-based method (typically with 0.6 × and 0.15 × ratios of AMPure XP beads) to enrich for fragments of the desired length. The purified library was eluted in 0.1 × TE buffer.
2.4.6 PCR amplification
The size-selected library was amplified by PCR using high-fidelity DNA polymerase and Illumina primer cocktails. The PCR conditions followed the manufacturer’s protocol.
2.4.7 Purification of PCR products
The PCR amplicons were purified using AMPure XP beads (0.8 × ratio), washed twice with 80% ethanol, air-dried, and eluted in nuclease-free water. The final library was quantified and stored at −20 °C.
2.4.8 Sequencing and primary bioinformatic processing
Sequencing was performed on an Illumina NovaSeq 6000 platform (Illumina, USA) to generate 150 bp paired-end reads. Raw sequencing data were processed as follows:
Quality control: Raw reads were quality-filtered and adapter-trimmed using Trimmomatic (v0.33) with default parameters. Host DNA Depletion: Reads aligning to the rat reference genome (mRn6) were identified and removed using Bowtie2 (v2.2.3). De novo Assembly: High-quality reads were de novo assembled into contigs using MEGAHIT (v1.1.2). Contigs shorter than 300 bp were discarded. Assembly quality was assessed using QUAST (v2.3). Gene Prediction: Open reading frames (ORFs) were predicted on the contigs using MetaGeneMark (v3.26). Non-redundant Gene Catalog Construction: Predicted protein sequences were clustered to remove redundancy using CD-HIT (v4.6.6) with parameters of 95% sequence identity and 90% coverage. The raw data, number of contigs assembled, and coverage for each sample are detailed in Supplementary Table S3.
2.4.9 KEGG functional annotation
Protein sequences from the non-redundant gene catalog were aligned against the KEGG database (Release 105.0) using DIAMOND (v0.9.24) with a maximum e-value threshold of 1 × 10−5. The best hit for each sequence was retained for functional assignment.
2.4.10 Functional diversity analysis
Based on the Kyoto Encyclopedia of Genes and Genomes (KEGG) annotation results, functional abundance profiles were generated. Subsequent analyses (e.g., PCA, differential abundance analysis) and visualization were performed using the BMK Cloud Metagenome Analysis system (Biomarker Technologies, China).
2.4.11 Taxonomic diversity analysis
Taxonomic profiling was performed by aligning the non-redundant gene sequences against the NR database using DIAMOND. The relative abundance of taxa at different taxonomic ranks was calculated. Community composition and diversity analyses were conducted and visualized via the BMK Cloud system.
2.5 Correlation analysis
Correlation analyses and visualizations were performed using the data visualization module of the ‘Wu Kong’ platform (available at: https://www.omicsolution.com/wkomics/main/) (Zhou et al., 2023).
2.6 Statistical analysis
Data are presented as mean ± SD. Statistical analyses were performed using SPSS 26.0. Between-group differences were assessed by an independent t-test with post hoc comparisons (SNK for equal variances; Dunnett’s T3 for unequal variances). Significance was defined as p < 0.05.
3 Result
3.1 Differential body weight changes under HSD
Body weight was measured at baseline (pre-intervention) and at weeks 2, 4, 6, and 8 during the modeling period, with specific values detailed in Supplementary Table S4. Longitudinal changes in body weight across groups are presented in Figure 2. During the initial 2 weeks, compared with the baseline level of this group, all groups exhibited significant weight gain, consistent with ongoing somatic development. Beyond this period, body weight plateaued or declined slightly, likely reflecting attenuated growth rates post-maturation.
Given inherent strain-dependent differences in body mass between Wistar and Dahl salt-sensitive rats, statistical comparisons were restricted within strains. At week 8, HSD increased the final body weight in Wistar rats, whereas it reduced weight in Dahl salt-sensitive rats. This difference response confirms systemic physiological alterations induced by HSD. Weight augmentation in the WH group may reflect hyperphagia secondary to sodium-enhanced palatability, whereas weight loss in the DH group suggests that salt sensitivity amplifies HSD-induced metabolic dysregulation. These metabolic perturbations prompted further investigation into intestinal barrier integrity and gut microbiota homeostasis.
3.2 HSD exacerbates systemic inflammation
To assess the impact of HSD-induced inflammation on intestinal integrity, plasma concentrations of inflammatory cytokines (including IL-1β, IL-6, IL-10, and TNF-α) were quantified across experimental groups. As depicted in Figure 3, these analyses revealed the implicated inflammatory pathways in HSD-associated pathophysiology. The specific values are detailed in Supplementary Table S5.
Figure 3. Inflammatory cytokine levels in rats (IL-1β, IL-6, IL-10, and TNF-α). *p < 0.05, **p < 0.01, ***p < 0.001.
HSD elicited strain-divergent pro-inflammatory responses: In Wistar rats, HSD significantly elevated IL-1β levels and suppressed IL-10 (p < 0.05), with concomitant upward trends in IL-6 and TNF-α. This pattern implicates IL-1β/IL-10 axis dysregulation as the primary driver of HSD-induced inflammation in this strain. Conversely, salt-sensitive rats exhibited attenuated interleukin responses to HSD, but showed marked TNF-α hyperinduction (p < 0.001). This TNF-α-dominated inflammatory signature suggests distinct mechanistic pathways underlying salt-sensitivity-associated tissue injury.
3.3 HSD-induced colon tissue damage
Histopathological assessment of rat colon sections (H&E/PAS staining) demonstrated that HSD induced significant colonic damage. The colon pathological sections of 200x and 400x magnifications among all groups are displayed in Figures 4, 5. HE staining revealed dense inflammatory infiltrates, crypt distortion, epithelial ulceration, and cellular degeneration. PAS staining concurrently demonstrated goblet cell depletion, mucin hyposecretion, and focal basement membrane fragmentation across magnifications, indicating critical mucin-physical barrier compromise. Crucially, the DH group exhibited more severe inflammatory damage, establishing that salt sensitivity potentiates HSD-induced intestinal barrier disruption through aggravating epithelial damage.
Figure 4. Histopathological analysis of colon tissues by H&E staining. (A, a) WC group. (B, b) WH group. (C, c) DC group. (D, d) DH group. Scale bars: 500 μm (A–D) and 100 μm (a–d).
Figure 5. Histopathological analysis of colon tissues by PAS staining. (A, a) WC group. (B, b) WH group. (C, c) DC group. (D, d) DH group. Scale bars: 500 μm (A–D) and 100 μm (a–d).
3.4 Metagenomic profiling of gut microbiota
To accurately investigate gut microbiome alterations induced by HSD intervention, fecal samples from all experimental groups underwent metagenomic sequencing. Due to inherent genetic differences between Wistar and Dahl salt-sensitive rat strains, analyses were performed separately to avoid confounding effects: comparisons were made between WC and WH groups, and between DC and DH groups. The species composition results from the fecal samples are shown in Figure 6. Almost all detected species are bacteria, which provides a basis for our subsequent metagenomic analysis of gut microbiota.
Figure 6. The species composition bar chart. The x-axis represents the sample name; the y-axis represents the relative abundance percentage. One color represents a species, and the length of the color block represents the relative abundance ratio of that species.
3.4.1 Gene composition and functional pathways
To compare gut microbial gene content between control and HSD groups, intergroup differential abundance of genes was visualized (Figure 7A). The analysis revealed that only ~30% of non-redundant genes were shared between groups. This indicates that high-salt intake altered gut microbiota gene composition, consequently affecting both the enrichment of associated metabolic pathways and microbiota structure.
Figure 7. Microbial gene composition and functional enrichment. (A) Venn diagram showing the number of shared and unique non-redundant genes among groups. (B) KEGG pathway enrichment analysis of gut microbial genes. The left panel displays a bar plot of the mean abundance of functional categories; the x-axis indicates the mean proportion, and the y-axis shows the names of functional pathways. The right panel shows the corresponding p-values. The significance level was set at *p < 0.05, **p < 0.01.
To analyze metabolic pathway changes resulting from gut microbial gene differences across groups, all genes were annotated to the KEGG database, and significantly enriched KEGG pathways (p < 0.05) were screened (Figure 7B, Supplementary Figure S1). KEGG pathway enrichment analysis revealed that compared with the WC group, the WH group showed significantly increased enrichment of gut microbial genes in carbohydrate metabolism and amino acid metabolism pathways (p < 0.05), significantly decreased enrichment in glycine biosynthesis, terpenoid and polyketide metabolism pathways (p < 0.05), and more pronounced decreased enrichment in lipid metabolism pathways (p < 0.01). Compared with the DC group, the DH group demonstrated significantly increased enrichment in amino acid metabolism pathways (p < 0.01), and significantly decreased enrichment in translation, nucleotide metabolism, replication and repair, folding/sorting/degradation, and transcription pathways (p < 0.05). In summary, HSD-induced gut microbial gene differences led to significant metabolic pathway variations between control and HSD groups, particularly in lipid and amino acid metabolism pathways.
3.4.2 Microbial community structure
Orthogonal Partial Least Squares Discriminant Analysis (OPLS-DA) is a supervised discriminant analysis method that decomposes data into predictive and orthogonal components through partial least squares regression with orthogonal signal correction. This approach enhances model interpretability by effectively separating biological signals from noise, making it suitable for complex datasets. As shown in Figure 8A, OPLS-DA revealed distinct clustering separation between control and HSD groups, indicating significant alterations in gut microbiota composition and reduced richness/diversity induced by high-salt intake.
Figure 8. Microbial community structure and intergroup disparities. (A) OPLS-DA score plot of gut microbial profiles. Each point represents an individual sample, with green and red dots indicating the control and HSD groups, respectively. The two components (x- and y-axes) explain the maximum variance between groups, with percentages indicating the contribution of each component to the overall model. (B) Analysis of intergroup differences. The bar chart shows the number of microbial species per group. The points and connecting lines below represent set intersections and the number of shared species.
As shown in Figure 8B, among all detected gut microbiota in Wistar rats, 269 species were exclusive to the WC group, while 330 species were exclusive to the WH group. Among all detected gut microbiota in Dahl salt-sensitive rats, 263 species were exclusive to the DC group, while 292 species were exclusive to the DH group. This ~15% compositional divergence between control and high-salt groups demonstrates that HSD alters gut microbial diversity.
3.4.3 Alpha diversity and F/B ratio
Alpha diversity indices (Shannon, Simpson, ACE, and Chao1) are established metrics for assessing gut microbial diversity and richness. The Shannon and Simpson indices measure species diversity, reflecting both richness (number of species) and evenness (relative abundance distribution). Higher Shannon and Simpson values indicate increased community evenness but decreased richness. Meanwhile, ACE and Chao1 indices quantify species richness (absolute number of microbial taxa), where elevated values denote higher richness. As shown in Figure 9A and Supplementary Table S6, the WH group versus WC group: ACE and Chao1 indices showed no significant difference, while Shannon (p < 0.05) and Simpson (p < 0.01) indices significantly increased, indicating enhanced diversity. The DH group versus DC group: Shannon and Simpson indices remained unchanged, but ACE and Chao1 indices exhibited a decreasing trend, suggesting reduced richness. The above results show that HSD not only alters gut microbial diversity but also reduces richness in rats.
Figure 9. Alpha diversity and F/B ratio. (A) Alpha diversity analysis of the gut microbiota. (B) The F/B ratio in each group of rats. *p < 0.05, **p < 0.01.
Over 30 bacterial phyla have been identified in the human gut microbiota, with their abundance and compositional changes closely linked to human health and disease. Firmicutes and Bacteroidetes constitute the majority of gut microbes. Post-infancy (>7 years), the Firmicutes/Bacteroidetes (F/B) ratio typically stabilizes, while its dysregulation is associated with metabolic disorders, including obesity and diabetes. As these two phyla comprise the majority of gut microbiota, shifts in their relative abundance reflect changes in dominant microbial species.
As shown in Figure 9B, HSD increased the F/B ratio in both Wistar and Dahl salt-sensitive rats. This indicates that high salt intake alters microbial richness, disrupts dominant phyla proportions, and induces gut dysbiosis.
3.4.4 Taxon-specific alterations
To further analyze the intergroup differences in gut microbiota, we identified the top 10 most abundant genera and visualized their relative abundance distribution in bar charts (Figure 10, Supplementary Tables S7, S8 and Figure S2).
Figure 10. Taxonomic composition of gut microbiota across experimental groups. The bar chart illustrates the relative abundance of bacterial taxa at the genus level. The x-axis represents the experimental groups, and the y-axis indicates the relative abundance (percentage). Each bar is color-coded to represent a distinct bacterial genus, and the height of each segment corresponds to its proportional abundance within the group.
In Wistar rats, compared with the WC group, the WH group exhibited decreased abundance of Bacteroides, Prevotella, Clostridium, Eubacterium, Lactobacillus, and Phocaeicola, but increased abundance of Escherichia, Faecalibaculum, Ruminococcus, and Allobaculum (Faecalibaculum significantly increased, p < 0.05).
In Dahl salt-sensitive rats, the DH group versus DC group displayed reduced abundance of Lactobacillus, Clostridium, Bacteroides, Prevotella, and Romboutsia (Clostridium significantly decreased, p < 0.05), alongside increased abundance of Faecalibaculum, Bifidobacterium, Eubacterium, Desulfovibrio, and Escherichia (Bifidobacterium significantly increased, p < 0.01).
In summary, HSD intervention altered the abundance of multiple bacterial genera, with particularly significant changes in Faecalibaculum, Clostridium, and Bifidobacterium.
3.5 Microbiota-inflammation correlations
Following the confirmation that HSD affects both inflammatory cytokines and gut microbiota, Pearson correlation analysis was performed to investigate potential associations between IL-1β, IL-6, IL-10, and TNF-α levels and significantly altered gut microbiota in high-salt groups. As shown in Figure 11, no significant correlations were observed between inflammatory cytokines and gut microbiota in Wistar rats (p > 0.05). However, in Dahl salt-sensitive rats, IL-1β levels showed a significant positive correlation with IL-6 levels (p < 0.05), while TNF-α levels exhibited a significant positive correlation with Bifidobacterium abundance (p < 0.05).
Figure 11. Correlation analysis between inflammatory cytokines and gut microbiota. (A) Wistar rats. (B) Dahl salt-sensitive rats. Shades of red represent positive correlations, while shades of blue represent negative correlations. An “×” denotes a statistically non-significant correlation (p > 0.05).
These findings indicate significant correlations between inflammatory cytokine levels and gut microbiota abundance in Dahl salt-sensitive rats under high-salt intervention, but not in Wistar rats. This suggests that Dahl salt-sensitive rats not only respond to HSD through different pathways compared to Wistar rats, but their salt-sensitive phenotype further amplifies the impact on gut microbial ecology.
4 Discussion
In recent years, the chronic health hazards associated with HSD have become a focus of scientific research (He et al., 2020; Stanzione et al., 2023). Building on previous studies, this experiment aimed to investigate how salt sensitivity modifies the effects of high salt intake and to explore the mechanisms by which high salt intake induces various diseases through alterations in gut microbiota. By identifying the specific microbial and metabolic signatures associated with the salt-sensitive phenotype, our study not only provides a new perspective on diet-host-microbiota crosstalk but also offers a rationale for targeted, personalized dietary interventions for salt-sensitive individuals.
The Wistar rat is one of the most commonly used laboratory rat strains. Dahl salt-sensitive rats were derived from the Wistar strain and are now widely employed in animal studies. While direct extrapolation from animal models to humans should be approached with caution, the specific microbiota–immune interaction mechanisms identified in the salt-sensitive rats provide a strong theoretical basis and research direction for identifying potential biomarkers and therapeutic targets in human populations, thereby offering valuable insights for future clinical translation. At the same time, this approach provides a preclinical analogue for the differences in the effects of a HSD on the general population and salt-sensitive individuals in this way, which is why we did not compare salt-resistant rats with salt-sensitive rats. Therefore, this study utilized both Wistar and Dahl salt-sensitive rats to compare the specific effects of salt sensitivity under high-salt conditions. It should be noted that only male animals were used in this study to minimize the potential confounding effects of estrogen (Baker et al., 2017; Braniste et al., 2014; Wang et al., 2022; Acharya et al., 2019). A notable observation was that HSD led to increased body weight in Wistar rats but decreased body weight in Dahl salt-sensitive rats, indicating that salt sensitivity exacerbates the detrimental physiological effects of high salt intake, resulting in weight loss (Bier et al., 2018).
Regarding inflammatory cytokines, the WH group exhibited significantly higher IL-1β levels and lower IL-10 levels compared to the WC group. Given that IL-1β promotes inflammatory and immune responses while IL-10 suppresses these processes (Wang et al., 2023; Kong et al., 2023), these results indicate the presence of inflammatory disruption in WH rats. Although no significant changes were observed in interleukins in the DH group, a notable increase in TNF-α levels also suggests inflammatory activation (Li et al., 2023; Zhang et al., 2022). This perspective is further supported by colon pathological sections, which revealed substantial damage to colonic cells and tissue structure in high-salt groups (Xia et al., 2017; Guo et al., 2019; Hu et al., 2026; Peng et al., 2024; Zha et al., 2024), particularly in the DH group (Li et al., 2025; Fan et al., 2025; Fan et al., 2025). The more severe intestinal damage observed in the DH group is likely attributable to the uniquely potent role of TNF-α in directly disrupting the epithelial barrier and inducing apoptosis, a mechanism distinct from the inflammation mediated by IL-1β and IL-6 (Bradley, 2008; Hosic et al., 2020; Gao et al., 2025).
Under physiological conditions, the gut microbiota maintains a dynamic equilibrium. It undergoes gradual adaptations in response to minor disturbances, tending to establish a new homeostatic state—a process underlying its role in modulating human health and contributing to disease development (Zhao et al., 2018). A study evaluating the impact of HSD on murine gut microbiota revealed that, compared with controls, mice fed the HSD exhibited reduced abundance of beneficial bacteria such as Lactobacillus, along with increased Th17 cells and decreased regulatory T cells (Tregs). Subsequent probiotic supplementation with Lactobacillus reversed these changes, reducing Th17 and increasing Treg populations (Wilck et al., 2017a,b; Wei et al., 2017). These findings demonstrate that high-salt intake disrupts microbial homeostasis, promotes inflammatory responses, and reduces Lactobacillus abundance (Nagase et al., 2020). Furthermore, HSD compromises microbial richness and diversity while concurrently activating inflammatory pathways (Ye et al., 2022; Wang et al., 2022). Gut microbiota dysregulation has been identified as one mechanism contributing to systemic inflammation, oxidative stress, and vascular injury in non-alcoholic fatty liver disease (Li et al., 2022). Under normal conditions, however, the gut microbiota helps mitigate lipid accumulation and prevent cardiovascular disease by modulating peripheral ketone body levels—effects attributed to beneficial genera such as Lactobacillus involved in lipid metabolism and regulation of unsaturated fatty acid and ketone synthesis and degradation (Zhai et al., 2022; Pokharel et al., 2023).
Our results revealed that only approximately 30% of non-redundant genes were shared between the control and high-salt groups, accompanied by about a 15% difference in microbial composition, indicating that the HSD altered gut microbiota homeostasis. To move from a descriptive account of dysbiosis to a functional one, we compared the enriched KEGG pathways across experimental groups, which revealed how the structural remodeling of the microbiota impacted its metabolic potential. Compared with the WC group, the WH group showed significantly reduced enrichment of microbial genes in lipid metabolism pathways, suggesting a decreased capacity for metabolizing lipids such as unsaturated fatty acids and ketone bodies, thereby increasing the risk of diseases such as atherosclerosis and fatty liver disease. In contrast, the DH group exhibited significantly increased enrichment in amino acid metabolism pathways compared to the DC group. Since amino acids serve as precursors for secondary bile acid synthesis, this implies that high salt intake may exert systemic effects by altering the composition and concentration of bile acids (Zeng et al., 2024). Alpha diversity analysis indicated reduced richness but increased diversity in the high-salt groups, manifested as an elevated F/B ratio (Tian et al., 2025). The observed increase in the F/B ratio under HSD is a crucial alteration. In our study, this ratio increase co-occurred with elevated systemic pro-inflammatory cytokines and colonic damage, strongly suggesting it contributes to the detrimental, rather than adaptive, host response (Canyelles et al., 2023). This finding finds resonance in human studies; for instance, an elevated F/B ratio has been consistently reported in cohorts of hypertensive (Tsiavos et al., 2024; Cai et al., 2023). The consistency between our model and human data underscores the F/B ratio as a conserved microbial feature of salt-related pathophysiology and reinforces the translational value of our experimental findings. Further taxonomic analysis revealed a significant increase in Enterobacter in the WH group, and a significant increase in Bifidobacterium, accompanied by a decrease in Clostridium in the DH group (Zheng et al., 2023a,b). Although not statistically significant, Lactobacillus showed a decreasing trend in both high-salt groups, suggesting a heightened risk of inflammatory responses (Do et al., 2022). Both Wistar and Dahl salt-sensitive rats exhibited gut microbiota dysbiosis following high-salt exposure, including increased inflammatory cytokines, colonic tissue injury, and alterations in microbial richness and composition. These findings indicate that high-salt intake itself acts as a strong perturbing factor, exerting detrimental effects across different genetic backgrounds. However, the DH groups displayed more severe colonic pathological injury and a greater reduction in specific bacterial taxa (e.g., Clostridium) compared with the WH group, suggesting that salt sensitivity amplifies the deleterious impact of high-salt intake. In terms of microbial composition, Faecalibaculum was markedly increased in Wistar rats, whereas Bifidobacterium was predominantly elevated in salt-sensitive rats. This implies that hosts with distinct genetic backgrounds may adopt different adaptive or pathological remodeling strategies in response to the same environmental stressor. At the metabolic pathway level, Wistar rats mainly showed downregulation of lipid metabolism (Xu et al., 2025; Liu et al., 2024; Boldarine et al., 2020), indicating that it may be related to the risk of cardiovascular diseases such as atherosclerosis. Salt-sensitive rats exhibited significant upregulation of amino acid metabolism, which was linked to secondary bile acid biosynthesis (Carvalho et al., 2024; Xu et al., 2023). This suggests that salt sensitivity may confer health risks through distinct metabolic axes.
Enterobacter, which includes opportunistic pathogens such as E. coli, may increase the risk of intestinal infections, diarrhea, and dysentery when enriched under high-salt conditions (Sun et al., 2020). Clostridium, a beneficial gut genus, alleviates inflammation and allergic reactions by activating intestinal epithelial cells, enhancing barrier function, and modulating immune activity (Guo et al., 2020). Bifidobacterium—like Lactobacillus and Clostridium arebeneficial bacteria used to treat diarrhea, constipation, and functional dyspepsia related to dysbiosis (Bertuccioli et al., 2025). The significant increase in Bifidobacterium may represent a compensatory response to offset immune risks associated with reduced Clostridium abundance. This shift may reflect a selective expansion of Bifidobacterium strains resilient to the high-salt and pro-inflammatory environment (Zheng et al., 2023a,b; Gandhi & Shah, 2016; Robles-Vera et al., 2020; Veselovsky et al., 2020), particularly as Bifidobacterium levels correlated positively with TNF-α in the DH group (Balan et al., 2022). Studies have shown that Th17 and Treg cell activities are influenced by the gut microbiota (Aguiar et al., 2018; Kleinewietfeld et al., 2013; Wu et al., 2013). Enterobacter, Clostridium, Bifidobacterium, and Lactobacillus collectively regulate intestinal immune responses via the Th17/Treg axis, suggesting that the gut microbiota represents a potential therapeutic target for mitigating disease risks induced by HSD (Pang et al., 2020). Our previous work has demonstrated that high-salt intake elevates blood pressure, impairs vascular endothelial function, and disrupts bile acid metabolism (Li et al., 2022). In the current study, we further observed that changes in body weight and systemic inflammatory cytokine levels represent reliable phenotypic indicators of high-salt–induced tissue injury and predictors of future metabolic and cardiovascular risk. Future studies will aim to integrate multi-system physiological parameters to provide a more comprehensive understanding of the systemic effects of high-salt intake.
The findings of this study provide several important insights into the adverse health impacts of high-salt intake in humans. First, the results suggest that individual salt sensitivity may represent a key determinant of dietary risk and should be given greater consideration in clinical nutritional assessment and personalized dietary guidance. Second, the identified microbial taxa (e.g., Clostridium, Bifidobacterium) and metabolic pathways (e.g., bile acid metabolism) may serve as potential biomarkers for evaluating high-salt exposure or the efficacy of interventions in human populations. Finally, targeted modulation of the gut microbiota through probiotic or microbiome-directed nutritional approaches may offer a novel strategy to protect salt-sensitive individuals from the detrimental effects of HSD. Notably, the translational relevance of our findings is supported by independent clinical data. A human study investigating the immune response to HSD (GEO: GSE265934) reported congruent microbial and immunological shifts, including an increase in Bifidobacterium abundance, elevated Th17 cell levels, and heightened gut permeability, which were associated with disease pathogenesis (Sharma et al., 2024). This consistency across species underscores the gut microbiota as a conserved player in salt-sensitive physiological disturbances and strengthens the potential translational impact of our mechanistic findings.
Looking forward, the correlative nature of this study underscores the necessity for future mechanistic investigations to establish causality. Specifically, fecal microbiota transplantation experiments are required to confirm whether the microbiota from salt-sensitive hosts is sufficient to transmit the phenotypic vulnerability. Furthermore, targeted interventional studies, such as administering probiotic strains or implementing personalized dietary salt modulation, are essential next steps to validate the therapeutic potential of manipulating the gut ecosystem.
5 Conclusion
This study comparatively analyzed the detrimental effects of the HSD on both general and salt-sensitive constitutions. Although the resulting damage and underlying mechanisms are similar between the two models, the key metabolites involved differ significantly, thus providing a theoretical basis for further targeted research. A limitation of this study is that neither Dahl salt-sensitive nor Wistar rats fully recapitulate human physiology. Nevertheless, our comparative metagenomic study demonstrates that host salt sensitivity is a pivotal factor shaping the gut microenvironment’s response to an HSD. It not only exacerbates the severity of microbial dysbiosis and intestinal damage but also steers the host-microbiota system toward distinct ecological and functional trajectories. The identified disparities in microbial consortia and metabolic pathways, coupled with their correlations to inflammatory markers, provide a novel mechanistic framework for understanding the heightened disease susceptibility in salt-sensitive individuals and highlight the gut microbiome as a promising target for future preventative strategies.
Data availability statement
The raw sequence data reported in this paper have been deposited in the Genome Sequence Archive (Zhang et al., 2025) in National Genomics Data Center (CNCB-NGDC Members and Partners, 2025), China National Center for Bioinformation/Beijing Institute of Genomics, Chinese Academy of Sciences (GSA: CRA035238) that are publicly accessible at https://ngdc.cncb.ac.cn/gsa.
Ethics statement
The animal study was approved by the Experimental Animal Ethics Committee of Chengdu University of Traditional Chinese Medicine. The study was conducted in accordance with the local legislation and institutional requirements.
Author contributions
BZ: Conceptualization, Formal analysis, Investigation, Methodology, Software, Validation, Visualization, Writing – original draft, Writing – review & editing. XP: Conceptualization, Investigation, Writing – review & editing. PX: Methodology, Visualization, Writing – review & editing. KN: Data curation, Validation, Writing – review & editing. GZ: Project administration, Supervision, Writing – review & editing. LX: Funding acquisition, Resources, Writing – review & editing.
Funding
The author(s) declare that financial support was received for the research and/or publication of this article. This research was funded by the National Natural Science Foundation of China, grant number 82274384, the Chengdu Municipal Science and Technology Bureau, grant number 2022-YF05-01469-SN, and the Sichuan Provincial Department of Science and Technology, grant numbers 2024NSFSC0717 and 2022SNZY004.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The authors declare that no Gen AI was used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmicb.2025.1718782/full#supplementary-material
References
Abdelnour, S. A., Abd, E. M., Noreldin, A. E., Batiha, G. E., Beshbishy, A. M., Ohran, H., et al. (2020). High salt diet affects the reproductive health in animals: an overview. Animals 10:590. doi: 10.3390/ani10040590
Acharya, K. D., Gao, X., Bless, E. P., Chen, J., and Tetel, M. J. (2019). Estradiol and high fat diet associate with changes in gut microbiota in female Ob/Ob mice. Sci. Rep. 9:20192. doi: 10.1038/s41598-019-56723-1,
Aguiar, S. L. F., Miranda, M. C. G., Guimarães, M. A. F., Santiago, H. C., Queiroz, C. P., Cunha, P. d. S., et al. (2018). High-salt diet induces IL-17-dependent gut inflammation and exacerbates colitis in mice. Front. Immunol. 8:1969. doi: 10.3389/fimmu.2017.01969,
Allen, L. A., Schmidt, J. R., Thompson, C. T., Carlson, B. E., Beard, D. A., and Lombard, J. H. (2019). High salt diet impairs cerebral blood flow regulation via salt-induced angiotensin II suppression. Microcirculation 26:e12518. doi: 10.1111/micc.12518,
Baker, J. M., Al-Nakkash, L., and Herbst-Kralovetz, M. M. (2017). Estrogen–gut microbiome axis: physiological and clinical implications. Maturitas 103, 45–53. doi: 10.1016/j.maturitas.2017.06.025,
Balan, Y., Packirisamy, R. M., and Mohanraj, P. S. (2022). High dietary salt intake activates inflammatory cascades via Th17 immune cells: impact on health and diseases. Arch. Med. Sci. 18, 459–465. doi: 10.5114/aoms.2020.96344,
Bertuccioli, A., Sisti, D., Lazzerini, N., Palazzi, C. M., Zonzini, G. B., Ragazzini, M., et al. (2025). Targeted probiotic therapy in irritable bowel syndrome: a clinical evaluation on Clostridium butyricum CBM588 and Bifidobacterium longum W11. Frontiers in medicine, 12:1604319. doi: 10.3389/fmed.2025.1604319
Bier, A., Braun, T., Khasbab, R., di Segni, A., Grossman, E., Haberman, Y., et al. (2018). A high salt diet modulates the gut microbiota and short chain fatty acids production in a salt-sensitive hypertension rat model. Nutrients 10:1154. doi: 10.3390/nu10091154,
Boldarine, V. T., Pedroso, A. P., Brandão-Teles, C., LoTurco, E. G., Nascimento, C. M. O., Oyama, L. M., et al. (2020). Ovariectomy modifies lipid metabolism of retroperitoneal white fat in rats: a proteomic approach. American journal of physiology. Endocrinology and metabolism, 319, E427–E437. doi: 10.1152/ajpendo.00094.2020
Bradley, J. R. (2008). TNF-mediated inflammatory disease. J. Pathol. 214, 149–160. doi: 10.1002/path.2287,
Braniste, V., Al-Asmakh, M., Kowal, C., et al. (2014). The gut microbiota influences blood-brain barrier permeability in mice. Sci. Transl. Med. 6:263ra158-263ra158. doi: 10.1126/scitranslmed.3009759,
Cai, M., Lin, L., Jiang, F., Peng, Y., Li, S., Chen, L., et al. (2023). Gut microbiota changes in patients with hypertension: a systematic review and meta-analysis. J. Clin. Hypertens. 25, 1053–1068. doi: 10.1111/jch.14722,
Canyelles, M., Borràs, C., Rotllan, N., Tondo, M., Escolà-Gil, J. C., and Blanco-Vaca, F. (2023). Gut microbiota-derived TMAO: a causal factor promoting atherosclerotic cardiovascular disease? Int. J. Mol. Sci. 24:1940. doi: 10.3390/ijms24031940,
Carvalho, M. S., Sforca, M. L., Rocco, S. A., Furtado, D. Z. S., Silverio, C. d. S., Nunes, M. F. Q., et al. (2024). Integration of proteinogenic amino acids in the pathogenesis of schizophrenia. Med. Adv. 2, 123–135. doi: 10.1002/med4.65
CNCB-NGDC Members and Partners. (2025). Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2025. Nucleic Acids Research. 53, D30–D44, doi: 10.1093/nar/gkae978
Do, N. L., de Souza, E. L., de Luna, F. M., et al. (2022). Limosilactobacillus fermentum prevents gut-kidney oxidative damage and the rise in blood pressure in male rat offspring exposed to a maternal high-fat diet. J. Dev. Orig. Health Dis. 13, 719–726. doi: 10.1017/S2040174422000198
Fan, F., Chen, M., Li, Y., Yan, J., Wang, X., Zhang, Y., et al. (2025). Association between systemic immune-inflammation indexes and Nuodikang capsule's protection in LPS-induced acute lung injury in mice. Phytomedicine 147:157229. doi: 10.1016/j.phymed.2025.157229,
Fan, S., Li, W. J., Qi, Y., et al. (2025). PRMT5 encourages cell migration and metastasis of tongue squamous cell carcinoma through methylating DeltaNp63alpha. Cell Death Differ. doi: 10.1038/s41418-025-01575-8
Feng, G., Zhuge, P., Zou, Y., Zhang, Z., Guo, J., and Ma, J. (2024). Distribution characteristics of intestinal flora in patients with OSAHS and the relationship between different intestinal flora and sleep disorders, hypoxemia and obesity. Sleep Breath. 28, 1155–1163. doi: 10.1007/s11325-024-02992-8,
Gandhi, A., and Shah, N. P. (2016). Salt reduction in a model high-salt Akawi cheese: effects on bacterial activity, pH, moisture, potential bioactive peptides, amino acids, and growth of human colon cells. J. Food Sci. 81, H991–H1000. doi: 10.1111/1750-3841.13260,
Gao, H., Sun, M., Li, A., Gu, Q., Kang, D., Feng, Z., et al. (2025). Microbiota-derived IPA alleviates intestinal mucosal inflammation through upregulating Th1/Th17 cell apoptosis in inflammatory bowel disease. Gut Microbes 17:2467235. doi: 10.1080/19490976.2025.2467235,
Guo, Q., Tang, Y., Li, Y., Xu, Z., Zhang, D., Liu, J., et al. (2021). Perinatal high-salt diet induces intestinal flora dysbiosis, bile acid homeostasis disbalance, and NAFLD in weanling mice offspring. Nutrients. 13:2135. doi: 10.3390/nu13072135
Guo, L., Xia, L., Zhou, X., et al. (2019). Effects of danshen on inflammatory cytokines in rats with high-salt induced blood stasis. Acta Med. Mediterr. 35, 373–377.
Guo, P., Zhang, K., Ma, X., and He, P. (2020). Clostridium species as probiotics: potentials and challenges. J. Anim. Sci. Biotechnol. 11:24. doi: 10.1186/s40104-019-0402-1,
He, F. J., Tan, M., Ma, Y., and MacGregor, G. A. (2020). Salt reduction to prevent hypertension and cardiovascular disease: JACC state-of-the-art review. J. Am. Coll. Cardiol. 75, 632–647. doi: 10.1016/j.jacc.2019.11.055,
Hosic, S., Lake, W., Stas, E., Koppes, R., Breault, D. T., Murthy, S. K., et al. (2020). Cholinergic activation of primary human derived intestinal epithelium does not ameliorate TNF-α induced injury. Cell. Mol. Bioeng. 13, 487–505. doi: 10.1007/s12195-020-00633-0,
Hu, Y., Fu, L., Ren, Q., Wang, F., Luo, H., Li, J., et al. (2026). Yu-ping-Feng nasal drops relieve allergic rhinitis via TRPV1/ca(2+)/NFAT pathway. J. Ethnopharmacol. 355:120618. doi: 10.1016/j.jep.2025.120618,
Huang, Y., Huang, X., Wang, Z., He, F., Huang, Z., Chen, C., et al. (2024). Analysis of differences in intestinal flora associated with different BMI status in colorectal cancer patients. J. Transl. Med. 22:142. doi: 10.1186/s12967-024-04903-7,
Kleinewietfeld, M., Manzel, A., Titze, J., Kvakan, H., Yosef, N., Linker, R. A., et al. (2013). Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 496, 518–522. doi: 10.1038/nature11868,
Kong, G., Chen, Y., Liu, Z., Wang, Y., Li, H., and Guo, C. (2023). Adenovirus-IL-10 relieves chronic rejection after mouse heart transplantation by inhibiting miR-155 and activating SOCS5. Int. J. Med. Sci. 20, 172–185. doi: 10.7150/ijms.77093,
Kwong, E., Whiting, S., Bunge, A. C., Kwong, E. J. L., Leven, Y., Breda, J., et al. (2023). Population-level salt intake in the WHO European region in 2022: a systematic review. Public Health Nutr. 26, s6–s19. doi: 10.1017/S136898002200218X,
Li, Q., Li, M., Li, F. H., et al. (2020). Qiang-Gan formula extract improves non-alcoholic steatohepatitis via regulating bile acid metabolism and intestinal flora in mice. J. Ethnopharmacol. 258:112896. doi: 10.1016/j.jep.2020.112896
Li, W., Liu, J., Cai, J., Zhang, X. J., Zhang, P., She, Z. G., et al. (2022). NAFLD as a continuous driver in the whole spectrum of vascular disease. J. Mol. Cell. Cardiol. 163, 118–132. doi: 10.1016/j.yjmcc.2021.10.007,
Li, W., Liu, Q., Shi, J., et al. (2023). The role of TNF-alpha in the fate regulation and functional reprogramming of mesenchymal stem cells in an inflammatory microenvironment. Front. Immunol. 14:1074863. doi: 10.3389/fimmu.2023.1074863
Li, J., Sun, Y., Wang, R., Ma, S., Shi, L., Wang, K., et al. (2023). Seasonal differences in intestinal flora are related to rats' intestinal water metabolism. Front. Microbiol. 14:1109696. doi: 10.3389/fmicb.2023.1109696,
Li, S. C., Wang, Q. H., Chen, L. F., Feng, S. Y., Wu, Y. X., and Yan, X. W. (2019). High sodium intake impairs small artery Vasoreactivity in vivo in Dahl salt-sensitive rats. J. Vasc. Res. 56, 65–76. doi: 10.1159/000498895,
Li, L., Xiao, Y., Zhou, J., Mo, H., Li, X., Li, Y., et al. (2024a). Effects of Berberine on glucolipid metabolism among dehydroepiandrosterone-induced rats of polycystic ovary syndrome with insulin-resistance. Heliyon 10:e24338. doi: 10.1016/j.heliyon.2024.e24338,
Li, L., Xiao, Y., Zhou, J., Mo, H., Li, X., Li, Y., et al. (2024b). Effects of Berberine on glucolipid metabolism among dehydroepiandrosterone-induced rats of polycystic ovary syndrome with insulin-resistance. Heliyon 10:e24338. doi: 10.1016/j.heliyon.2024.e24338,
Li, L., Zhong, S., Liang, H., Hu, S. Y., and Hu, Z. X. (2025). Associations between gut microbiota, short-chain fatty acids, and high-salt diet-induced hypertension in rats. Curr. Med. Sci. 45, 715–724. doi: 10.1007/s11596-025-00077-5,
Liu, Y.-F., Ling, N., Zhang, B., Chen, C., Mo, X.-N., Cai, J.-Y., et al. (2024). Flavonoid-rich mulberry leaf extract modulate lipid metabolism, antioxidant capacity, and gut microbiota in high-fat diet-induced obesity: potential roles of FGF21 and SOCS2. Food Med. Homol. 1:9420016. doi: 10.26599/FMH.2024.9420016
Ma, J. L., Hong, Y., Zheng, N. N., et al. (2020). Gut microbiota remodeling reverses aging-associated inflammation and dysregulation of systemic bile acid homeostasis in mice sex-specifically. Gut Microbes 11, 1450–1474. doi: 10.1080/19490976.2020.1763770,
Miranda, P. M., De Palma, G., Serkis, V., et al. (2018). High salt diet exacerbates colitis in mice by decreasing Lactobacillus levels and butyrate production. Microbiome 6:57. doi: 10.1186/s40168-018-0433-4,
Monteleone, I., Marafini, I., Dinallo, V., di Fusco, D., Troncone, E., Zorzi, F., et al. (2017). Sodium chloride–enriched diet enhanced inflammatory cytokine production and exacerbated experimental colitis in mice. J. Crohn's Colitis 11, 237–245. doi: 10.1093/ecco-jcc/jjw139,
Mu, Y. F., Gao, Z. X., Mao, Z. H., Pan, S. K., Liu, D. W., Liu, Z. S., et al. (2024a). Perspectives on the involvement of the gut microbiota in salt-sensitive hypertension. Hypertens. Res. 47, 2351–2362. doi: 10.1038/s41440-024-01747-y,
Mu, Y. F., Gao, Z. X., Mao, Z. H., Pan, S. K., Liu, D. W., Liu, Z. S., et al. (2024b). Perspectives on the involvement of the gut microbiota in salt-sensitive hypertension. Hypertens. Res. 47, 2351–2362. doi: 10.1038/s41440-024-01747-y,
Nagase, S., Karashima, S., Tsujiguchi, H., Tsuboi, H., Miyagi, S., Kometani, M., et al. (2020). Impact of gut microbiome on hypertensive patients with low-salt intake: Shika study results. Front. Med. 7:475. doi: 10.3389/fmed.2020.00475,
Padhi, P., Worth, C., Zenitsky, G., Jin, H., Sambamurti, K., Anantharam, V., et al. (2022). Mechanistic Insights Into Gut Microbiome Dysbiosis-Mediated Neuroimmune Dysregulation and Protein Misfolding and Clearance in the Pathogenesis of Chronic Neurodegenerative Disorders. Frontiers in neuroscience, 16:836605. doi: 10.3389/fnins.2022.836605
Pang, H., Xin, X., He, J., Cui, B., Guo, D., Liu, S., et al. (2020). Effect of NaCl concentration on microbiological properties in NaCl assistant anaerobic fermentation: hydrolase activity and microbial community distribution. Front. Microbiol. 11:589222. doi: 10.3389/fmicb.2020.589222,
Peng, X., Liu, N., Zeng, B., Bai, Y., Xu, Y., Chen, Y., et al. (2024). High salt diet accelerates skin aging in wistar rats: an 8-week investigation of cell cycle inhibitors, SASP markers, and oxidative stress. Frontiers in bioengineering and biotechnology, 12:1450626. doi: 10.3389/fbioe.2024.1450626
Pokharel, P., Dhakal, S., and Dozois, C. M. (2023). The diversity of Escherichia coli Pathotypes and vaccination strategies against this versatile bacterial pathogen. Microorganisms 11. doi: 10.3390/microorganisms11020344,
Robles-Vera, I., de la Visitación, N., Toral, M., Sánchez, M., Romero, M., Gómez-Guzmán, M., et al. (2020). Probiotic Bifidobacterium breve prevents DOCA-salt hypertension. FASEB J. 34, 13626–13640. doi: 10.1096/fj.202001532R,
Sharma, M., Dey, U., Das, A. S., et al. (2024). Anti-tumor potential of high salt in breast cancer cell lines. Mol. Biol. Rep. 51:1002. doi: 10.1007/s11033-024-09925-4
Shen, H. R., Xu, X., Ye, D., and Li, X. L. (2021). Berberine Improves the Symptoms of DHEA-Induced PCOS Rats by Regulating Gut Microbiotas and Metabolites. Gynecologic and obstetric investigation, 86, 388–397. doi: 10.1159/000518040
Stanzione, R., Forte, M., Cotugno, M., Oppedisano, F., Carresi, C., Marchitti, S., et al. (2023). Beneficial effects of Citrus Bergamia polyphenolic fraction on saline load-induced injury in primary cerebral endothelial cells from the stroke-prone spontaneously hypertensive rat model. Nutrients 15. doi: 10.3390/nu15061334,
Sun, Y., Huang, Y., Ye, F., Liu, W., Jin, X., Lin, K., et al. (2020). Effects of probiotics on glycemic control and intestinal dominant flora in patients with type 2 diabetes mellitus: a protocol for systematic review and meta-analysis. Medicine 99:e23039. doi: 10.1097/MD.0000000000023039,
Tian, H., Gao, X., Du, H., et al. (2025). Changes in microbial and metabolic profiles of mice fed with long-term high salt diet. BMC Gastroenterol. 25:375. doi: 10.1186/s12876-025-03929-5,
Tsiavos, A., Antza, C., Trakatelli, C., and Kotsis, V. (2024). The microbial perspective: a systematic literature review on hypertension and gut microbiota. Nutrients 16:3698. doi: 10.3390/nu16213698,
Veselovsky, V. A., Dyachkova, M. S., Menyaylo, E. A., Polyaeva, P. S., Olekhnovich, E. I., Shitikov, E. A., et al. (2020). Gene Networks Underlying the Resistance of Bifidobacterium longum to Inflammatory Factors. Frontiers in immunology, 11:595877. doi: 10.3389/fimmu.2020.595877
Wang, L., Hu, J., and Ren, K. (2025). The multifaceted impact of a high-salt environment on the immune system and its contribution to salt-sensitive hypertension. Biochem. Biophys. Rep. 44:102244. doi: 10.1016/j.bbrep.2025.102244,
Wang, R. P., Huang, J., Chan, K., et al. (2023). IL-1beta and TNF-alpha play an important role in modulating the risk of periodontitis and Alzheimer's disease. J. Neuroinflammation 20:71. doi: 10.1186/s12974-023-02747-4
Wang, X., Lang, F., and Liu, D. (2024). High-salt diet and intestinal microbiota: influence on cardiovascular disease and inflammatory bowel disease. Biology 13:674. doi: 10.3390/biology13090674,
Wang, X., Liu, Y., Wang, Y., Dong, X., Wang, Y., Yang, X., et al. (2022). Protective effect of coriander (Coriandrum sativum L.) on high-fructose and high-salt diet-induced hypertension: relevant to improvement of renal and intestinal function. J. Agric. Food Chem. 70, 3730–3744. doi: 10.1021/acs.jafc.2c00267,
Wang, S., Wang, S., Wang, X., Xu, Y., Zhang, X., Han, Y., et al. (2022). Effects of icariin on modulating gut microbiota and regulating metabolite alterations to prevent bone loss in ovariectomized rat model. Front. Endocrinol. 13:874849. doi: 10.3389/fendo.2022.874849,
Wei, Y., Lu, C., Chen, J., Cui, G., Wang, L., Yu, T., et al. (2017). High salt diet stimulates gut Th17 response and exacerbates TNBS-induced colitis in mice. Oncotarget, 8, 70–82. doi: 10.18632/oncotarget.13783
Wilck, N., Matus, M. G., Kearney, S. M., Olesen, S. W., Forslund, K., Bartolomaeus, H., et al. (2017a). Salt-responsive gut commensal modulates TH17 axis and disease. Nature 551, 585–589. doi: 10.1038/nature24628,
Wilck, N., Matus, M. G., Kearney, S. M., Olesen, S. W., Forslund, K., Bartolomaeus, H., et al. (2017b). Salt-responsive gut commensal modulates T(H)17 axis and disease. Nature 551, 585–589. doi: 10.1038/nature24628,
Wu, C., Yosef, N., Thalhamer, T., Zhu, C., Xiao, S., Kishi, Y., et al. (2013). Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature 496, 513–517. doi: 10.1038/nature11984,
Xia, L., Zhou, X., Tian, X., et al. (2017). Effect of salvia miltiorrhiza on tmmrna expression in coronary artery tissue of rats with high salt induced blood stasis. J. Investig. Med. 65, A6.1–A6.
Xu, C., Wang, J.-Y., Wang, C.-L., et al. (2025). Current perspectives and trends of lipid metabolism in chronic kidney diseases: a bibliometric analysis. Food Med. Homol. doi: 10.26599/FMH.2026.9420112
Xu, F., Yu, P., Wu, H., Liu, M., Liu, H., Zeng, Q., et al. (2024). Aqueous extract of Sargentodoxa cuneata alleviates ulcerative colitis and its associated liver injuries in mice through the modulation of intestinal flora and related metabolites. Front. Microbiol. 15:1295822. doi: 10.3389/fmicb.2024.1295822,
Xu, Y., Zhao, Z., Yan, E. P., Lian, Z.‐. X., and Zhang, W. (2023). Complex interplay between the immune system, metabolism, and epigenetic factors in autoimmune liver diseases. Med. Adv. 1, 97–114. doi: 10.1002/med4.23
Yan, X., Jin, J., Su, X., Yin, X., Gao, J., Wang, X., et al. (2020a). Intestinal Flora modulates blood pressure by regulating the synthesis of intestinal-derived corticosterone in high salt-induced hypertension. Circ. Res. 126, 839–853. doi: 10.1161/CIRCRESAHA.119.316394,
Yan, X., Jin, J., Su, X., Yin, X., Gao, J., Wang, X., et al. (2020b). Intestinal Flora modulates blood pressure by regulating the synthesis of intestinal-derived corticosterone in high salt-induced hypertension. Circ. Res. 126, 839–853. doi: 10.1161/CIRCRESAHA.119.316394,
Ye, X., Tang, X., Li, F., Zhu, J., Wu, M., Wei, X., et al. (2022). Green and oolong tea extracts with different phytochemical compositions prevent hypertension and modulate the intestinal Flora in a high-salt diet fed Wistar rats. Front. Nutr. 9:892801. doi: 10.3389/fnut.2022.892801,
Zeng, B., Peng, X., Chen, L., Liu, J., and Xia, L. (2024). Bile acid metabolism analysis provides insights into vascular endothelial injury in salt-sensitive hypertensive rats. Meta 14:452. doi: 10.3390/metabo14080452,
Zha, A., Qi, M., Deng, Y., Li, H., Wang, N., Wang, C., et al. (2024). Gut Bifidobacterium pseudocatenulatum protects against fat deposition by enhancing secondary bile acid biosynthesis. iMeta, 3:e261. doi: 10.1002/imt2.261
Zhai, T., Ren, W., Wang, P., and Zheng, L. (2022). Lactobacillus rhamnosus GG protects against atherosclerosis by improving ketone body synthesis. Appl. Microbiol. Biotechnol. 106, 8233–8243. doi: 10.1007/s00253-022-12265-7,
Zhang, S., Chen, X., Jin, E., Wang, A., Chen, T., Zhang, X., et al. (2025). The GSA Family in 2025: A Broadened Sharing Platform for Multi-omics and Multimodal Data. Genomics, Proteomics and Bioinformatics. 23:qzaf072. doi: 10.1093/gpbjnl/qzaf072
Zhang, L., Wang, X., and Zhang, X. (2022). Modulation of intestinal Flora by dietary polysaccharides: a novel approach for the treatment and prevention of metabolic disorders. Foods 11:2961. doi: 10.3390/foods11192961,
Zhang, Z., Zhao, L., Zhou, X., et al. (2022). Role of inflammation, immunity, and oxidative stress in hypertension: new insights and potential therapeutic targets. Front. Immunol. 13:1098725.
Zhao, L., Zhang, F., Ding, X., Wu, G., Lam, Y. Y., Wang, X., et al. (2018). Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science 359, 1151–1156. doi: 10.1126/science.aao5774,
Zheng, T., Wu, Y., Guo, K., Tan, Z. J., and Yang, T. (2023a). The process of hypertension induced by high-salt diet: association with interactions between intestinal mucosal microbiota, and chronic low-grade inflammation, end-organ damage. Front. Microbiol. 14:1123843. doi: 10.3389/fmicb.2023.1123843,
Zheng, T., Wu, Y., Guo, K., Tan, Z. J., and Yang, T. (2023b). The process of hypertension induced by high-salt diet: association with interactions between intestinal mucosal microbiota, and chronic low-grade inflammation, end-organ damage. Front. Microbiol. 14:1123843. doi: 10.3389/fmicb.2023.1123843,
Keywords: high salt diet, salt sensitivity, gut microbiota, metagenomics, intestinal barrier disruption
Citation: Zeng B, Peng X, Xiao P, Nie K, Zhang G and Xia L (2026) Salt sensitivity potentiates high-salt diet-induced intestinal barrier disruption and gut microbiome dysbiosis in rats. Front. Microbiol. 16:1718782. doi: 10.3389/fmicb.2025.1718782
Edited by:
Charalampia Amerikanou, Harokopio University, GreeceReviewed by:
Wenyi Kang, Henan University, ChinaMan Sau Wong, Hong Kong Polytechnic University, Hong Kong SAR, China
Valentin Schatz, University Hospital of Cologne, Germany
Copyright © 2026 Zeng, Peng, Xiao, Nie, Zhang and Xia. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Lina Xia, eGlhbGluYUBjZHV0Y20uZWR1LmNu
†These authors have contributed equally to this work
Pengyang Xiao†